Rosenstock J - Search Results

1

Counterpoint: Inpatient glucose management: a premature call to arms?

Inzucchi SE, Rosenstock J. Inzucchi SE, et al. Among authors: rosenstock j. Diabetes Care. 2005 Apr;28(4):976-9. doi: 10.2337/diacare.28.4.976. Diabetes Care. 2005. PMID: 15793210 Review. No abstract available.

2

Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

Rosenstock J, Cappelleri JC, Bolinder B, Gerber RA. Rosenstock J, et al. Diabetes Care. 2004 Jun;27(6):1318-23. doi: 10.2337/diacare.27.6.1318. Diabetes Care. 2004. PMID: 15161782

3

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Rosenstock J, et al. Diabetes Care. 2005 Apr;28(4):950-5. doi: 10.2337/diacare.28.4.950. Diabetes Care. 2005. PMID: 15793205

4

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD. Kendall DM, et al. Among authors: rosenstock j. Diabetes Care. 2005 May;28(5):1083-91. doi: 10.2337/diacare.28.5.1083. Diabetes Care. 2005. PMID: 15855571 Clinical Trial.

5

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G. Rosenstock J, et al. Diabetes Care. 2006 Mar;29(3):554-9. doi: 10.2337/diacare.29.03.06.dc05-0695. Diabetes Care. 2006. PMID: 16505505 Clinical Trial.

6

Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.

Rosenstock J, Baron MA, Dejager S, Mills D, Schweizer A. Rosenstock J, et al. Diabetes Care. 2007 Feb;30(2):217-23. doi: 10.2337/dc06-1815. Diabetes Care. 2007. PMID: 17259484 Clinical Trial.

7

Comparison of standard (self-directed) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measures.

Rosenstock J, Nakano M, Silverman BL, Sun B, de la Peña A, Suri A, Muchmore DB. Rosenstock J, et al. Diabetes Technol Ther. 2007 Feb;9(1):80-8. doi: 10.1089/dia.2006.0042. Diabetes Technol Ther. 2007. PMID: 17316102 Clinical Trial.

8

A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.

Rosenstock J, Hollander P, Gadde KM, Sun X, Strauss R, Leung A; OBD-202 Study Group. Rosenstock J, et al. Diabetes Care. 2007 Jun;30(6):1480-6. doi: 10.2337/dc06-2001. Epub 2007 Mar 15. Diabetes Care. 2007. PMID: 17363756 Clinical Trial.

9

Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.

Rosenstock J, Ahmann AJ, Colon G, Scism-Bacon J, Jiang H, Martin S. Rosenstock J, et al. Diabetes Care. 2008 Jan;31(1):20-5. doi: 10.2337/dc07-1122. Epub 2007 Oct 12. Diabetes Care. 2008. PMID: 17934150 Clinical Trial.

10

Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus.

Rosenstock J, Zinman B. Rosenstock J, et al. Curr Opin Endocrinol Diabetes Obes. 2007 Apr;14(2):98-107. doi: 10.1097/MED.0b013e3280a02f65. Curr Opin Endocrinol Diabetes Obes. 2007. PMID: 17940427 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters